Comp Hepatol. 2004 Jan 14;3 Suppl 1:S3.

Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis.

Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka 545-8585, Japan. kawadanori@med.osaka-cu.ac.jp

PMID: 14960155 [PubMed - as supplied by publisher]PMCID: PMC2410226Free PMC Article

LinkOut - more resources

Full Text Sources:

Libraries:

LinkOut Holdings

Supplemental Content

Related citations

Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. [Liver Transpl. 2005]
Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW. Liver Transpl. 2005 Oct; 11(10):1235-41.
Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. [Gastroenterology. 2005]
Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis.
Oakley F, Meso M, Iredale JP, Green K, Marek CJ, Zhou X, May MJ, Millward-Sadler H, Wright MC, Mann DA. Gastroenterology. 2005 Jan; 128(1):108-20.
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. [Gastroenterology. 2006]
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B. Gastroenterology. 2006 Feb; 130(2):435-52.
Review Hepatic stellate cells and alcoholic liver disease. [Rev Esp Enferm Dig. 2006]
Review Hepatic stellate cells and alcoholic liver disease.
Vera M, Nieto N. Rev Esp Enferm Dig. 2006 Sep; 98(9):674-84.
Review Gene modulation for treating liver fibrosis. [Crit Rev Ther Drug Carrier Syst. 2007]
Review Gene modulation for treating liver fibrosis.
Cheng K, Mahato RI. Crit Rev Ther Drug Carrier Syst. 2007; 24(2):93-146.

See reviews... See all...

All links from this record

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Molecular mechanism of stellate cell activation and therapeutic strategy for liv...
Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis.
Comp Hepatol. 2004 Jan 14;3 Suppl 1:S3.

PubMed
Related Citations for PubMed (Select 20051112) (100)
PubMed
Related Citations for PubMed (Select 14960153) (130)
PubMed
Amino acids, L-Cysteine and L-Methionine, Attenuate Activation of Rat Stellate C...
Amino acids, L-Cysteine and L-Methionine, Attenuate Activation of Rat Stellate Cells in Primary Culture.
Comp Hepatol. 2004 Jan 14;3 Suppl 1:S9.

PubMed
Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human l...
Expression of leukemia inhibitory factor (LIF) and its receptor gp190 in human liver and in cultured human liver myofibroblasts. Cloning of new isoforms of LIF mRNA.
Comp Hepatol. 2004 Nov 26;3(1):10.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Molecular mechanism of stellate cell activation and therapeutic strategy for liver fibrosis.

LinkOut - more resources

Full Text Sources:

Libraries:

Supplemental Content

Related citations

All links from this record

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information